NCT04741789 2026-03-16
Managed Access Programs for INC280, Capmatinib
Novartis
No longer available
Clinical Trials
22 trialsNCT07399015 2026-02-18
Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC
Endevica Bio
No longer available
NCT06439966 2026-02-12
Expanded Access to ABBV-787
AbbVie
No longer available
NCT06195514 2026-01-30
Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)
Takeda
No longer available
NCT03756311 2026-01-23
Expanded Access to NanoPac
NanOlogy, LLC
No longer available
NCT04060628 2026-01-23
Expanded Access to NanoDoce
NanOlogy, LLC
No longer available
NCT06063746 2026-01-08
Compassionate Use of Vidutolimod
Regeneron Pharmaceuticals
No longer available
NCT06841874 2025-12-24
Tale EAP
Nuvation Bio Inc.
No longer available
NCT04489433 2025-12-18
Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma
Novartis
No longer available
NCT06590480 2025-12-18
RPL-EAP-001
Replimune Inc.
No longer available
NCT05161598 2025-12-16
Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
Janssen Research & Development, LLC
No longer available
NCT03523338 2025-12-10
An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc.
No longer available
NCT05269771 2025-11-05
MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera
Novartis
No longer available
NCT04087889 2025-09-29
Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer
Hope Biosciences Research Foundation
No longer available
NCT05918913 2025-09-05
Expanded Access Program for Revumenib
Syndax Pharmaceuticals
No longer available
NCT04681248 2025-08-03
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
Leap Therapeutics, Inc.
No longer available
NCT04313075 2025-07-15
A Compassionate Use Study of Leronlimab in Breast Cancer
CytoDyn, Inc.
No longer available
NCT04452994 2025-06-13
Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple Myeloma
Janssen Research & Development, LLC
No longer available
NCT06099639 2025-06-08
Medical Access Program for Patritumab Deruxtecan
Daiichi Sankyo
No longer available
NCT03593499 2025-05-31
Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401
Biogen
No longer available
NCT04578444 2025-05-25
An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer
Jazz Pharmaceuticals
No longer available
NCT04087876 2025-04-06
Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations
Basilea Pharmaceutica
No longer available